vs
德康医疗(DXCM)与新闻集团(NWSA)财务数据对比。点击上方公司名可切换其他公司
新闻集团的季度营收约是德康医疗的1.9倍($2.4B vs $1.3B),德康医疗净利率更高(21.2% vs 8.2%,领先13.0%),德康医疗同比增速更快(21.6% vs 5.5%),过去两年德康医疗的营收复合增速更高(12.0% vs -1.3%)
德康医疗是美国跨国医疗保健企业,专注于研发、生产及销售糖尿病管理领域的连续血糖监测(CGM)系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥,生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
新闻集团是全球知名的媒体集团,旗下拥有报纸、出版、数字媒体等多项媒体业务,在全球传媒领域拥有广泛影响力,专注于为受众提供及时多元的时事资讯与内容服务。
DXCM vs NWSA — 直观对比
营收规模更大
NWSA
是对方的1.9倍
$1.3B
营收增速更快
DXCM
高出16.0%
5.5%
净利率更高
DXCM
高出13.0%
8.2%
两年增速更快
DXCM
近两年复合增速
-1.3%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $1.3B | $2.4B |
| 净利润 | $267.3M | $193.0M |
| 毛利率 | 62.9% | — |
| 营业利润率 | 25.6% | — |
| 净利率 | 21.2% | 8.2% |
| 营收同比 | 21.6% | 5.5% |
| 净利润同比 | 153.6% | -10.2% |
| 每股收益(稀释后) | $0.67 | $0.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DXCM
NWSA
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $2.4B | ||
| Q3 25 | $1.2B | $2.1B | ||
| Q2 25 | $1.2B | $1.6B | ||
| Q1 25 | $1.0B | $2.0B | ||
| Q4 24 | $1.1B | $2.2B | ||
| Q3 24 | $994.2M | $2.6B | ||
| Q2 24 | $1.0B | $2.6B |
净利润
DXCM
NWSA
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $193.0M | ||
| Q3 25 | $283.8M | $112.0M | ||
| Q2 25 | $179.8M | $743.0M | ||
| Q1 25 | $105.4M | $103.0M | ||
| Q4 24 | $151.7M | $215.0M | ||
| Q3 24 | $134.6M | $119.0M | ||
| Q2 24 | $143.5M | $50.0M |
毛利率
DXCM
NWSA
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
营业利润率
DXCM
NWSA
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | — | ||
| Q3 25 | 20.1% | — | ||
| Q2 25 | 18.4% | 8.5% | ||
| Q1 25 | 12.9% | 7.5% | ||
| Q4 24 | 17.0% | 19.2% | ||
| Q3 24 | 15.3% | 7.9% | ||
| Q2 24 | 15.7% | 4.3% |
净利率
DXCM
NWSA
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 8.2% | ||
| Q3 25 | 23.5% | 5.2% | ||
| Q2 25 | 15.5% | 45.6% | ||
| Q1 25 | 10.2% | 5.1% | ||
| Q4 24 | 13.6% | 9.6% | ||
| Q3 24 | 13.5% | 4.6% | ||
| Q2 24 | 14.3% | 1.9% |
每股收益(稀释后)
DXCM
NWSA
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.34 | ||
| Q3 25 | $0.70 | $0.20 | ||
| Q2 25 | $0.45 | $1.30 | ||
| Q1 25 | $0.27 | $0.18 | ||
| Q4 24 | $0.37 | $0.38 | ||
| Q3 24 | $0.34 | $0.21 | ||
| Q2 24 | $0.35 | $0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $2.1B |
| 总债务越低越好 | — | $2.0B |
| 股东权益账面价值 | $2.7B | $8.8B |
| 总资产 | $6.3B | $15.5B |
| 负债/权益比越低杠杆越低 | — | 0.22× |
8季度趋势,按日历期对齐
现金及短期投资
DXCM
NWSA
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $2.1B | ||
| Q3 25 | $1.8B | $2.2B | ||
| Q2 25 | $1.2B | $2.4B | ||
| Q1 25 | $904.9M | $2.1B | ||
| Q4 24 | $606.1M | $1.8B | ||
| Q3 24 | $621.2M | $1.8B | ||
| Q2 24 | $939.2M | $2.0B |
总债务
DXCM
NWSA
| Q1 26 | — | — | ||
| Q4 25 | — | $2.0B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.9B | ||
| Q2 24 | — | $2.9B |
股东权益
DXCM
NWSA
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $8.8B | ||
| Q3 25 | $2.7B | $8.7B | ||
| Q2 25 | $2.6B | $8.8B | ||
| Q1 25 | $2.3B | $8.2B | ||
| Q4 24 | $2.1B | $8.1B | ||
| Q3 24 | $2.0B | $8.3B | ||
| Q2 24 | $2.4B | $8.1B |
总资产
DXCM
NWSA
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $15.5B | ||
| Q3 25 | $7.5B | $15.3B | ||
| Q2 25 | $7.3B | $15.5B | ||
| Q1 25 | $6.8B | $16.6B | ||
| Q4 24 | $6.5B | $16.2B | ||
| Q3 24 | $6.4B | $16.9B | ||
| Q2 24 | $6.8B | $16.7B |
负债/权益比
DXCM
NWSA
| Q1 26 | — | — | ||
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.35× | ||
| Q2 24 | — | 0.36× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $231.0M |
| 自由现金流经营现金流 - 资本支出 | — | $132.0M |
| 自由现金流率自由现金流/营收 | — | 5.6% |
| 资本支出强度资本支出/营收 | — | 4.2% |
| 现金转化率经营现金流/净利润 | — | 1.20× |
| 过去12个月自由现金流最近4个季度 | — | $586.0M |
8季度趋势,按日历期对齐
经营现金流
DXCM
NWSA
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $231.0M | ||
| Q3 25 | $659.9M | $85.0M | ||
| Q2 25 | $303.0M | $189.0M | ||
| Q1 25 | $183.8M | $511.0M | ||
| Q4 24 | $301.4M | $252.0M | ||
| Q3 24 | $199.5M | $64.0M | ||
| Q2 24 | $279.4M | $254.0M |
自由现金流
DXCM
NWSA
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $132.0M | ||
| Q3 25 | $579.4M | $4.0M | ||
| Q2 25 | $208.9M | $32.0M | ||
| Q1 25 | $96.8M | $418.0M | ||
| Q4 24 | $176.8M | $190.0M | ||
| Q3 24 | $88.3M | $-31.0M | ||
| Q2 24 | $213.3M | $111.0M |
自由现金流率
DXCM
NWSA
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 5.6% | ||
| Q3 25 | 47.9% | 0.2% | ||
| Q2 25 | 18.1% | 2.0% | ||
| Q1 25 | 9.3% | 20.8% | ||
| Q4 24 | 15.9% | 8.5% | ||
| Q3 24 | 8.9% | -1.2% | ||
| Q2 24 | 21.2% | 4.3% |
资本支出强度
DXCM
NWSA
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 4.2% | ||
| Q3 25 | 6.7% | 3.8% | ||
| Q2 25 | 8.1% | 9.6% | ||
| Q1 25 | 8.4% | 4.6% | ||
| Q4 24 | 11.2% | 2.8% | ||
| Q3 24 | 11.2% | 3.7% | ||
| Q2 24 | 6.6% | 5.5% |
现金转化率
DXCM
NWSA
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 1.20× | ||
| Q3 25 | 2.33× | 0.76× | ||
| Q2 25 | 1.69× | 0.25× | ||
| Q1 25 | 1.74× | 4.96× | ||
| Q4 24 | 1.99× | 1.17× | ||
| Q3 24 | 1.48× | 0.54× | ||
| Q2 24 | 1.95× | 5.08× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
NWSA
| Book Publishing Segment | $633.0M | 27% |
| Consumer | $607.0M | 26% |
| News And Information Services Segment | $570.0M | 24% |
| Real Estate | $401.0M | 17% |
| Other Product Or Service | $173.0M | 7% |